Possible role of tau protein kinases in pathogenesis of Alzheimer's disease

Neurobiology of Aging

Volumn 19, Issue SUPPL. 1, 1998, Pages

  Imahori, K ^a   Hoshi, M ^a   Ishiguro, K ^a   Sato, K ^a   Takahashi, M ^a   Shiurba, R ^a   Yamaguchi, H ^b   Takashima, A ^a   Uchida, T ^a  

^a MITSUBISHI KASEI INST OF LIFE SCI   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Amyloid protein; Pyruvate dehydrogenase; Tau protein kinases I and II

Indexed keywords

ACETYLCHOLINE; PHOSPHOTRANSFERASE; PYRUVATE DEHYDROGENASE; TAU PROTEIN; TAU PROTEIN KINASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HIPPOCAMPUS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL;

ALZHEIMER DISEASE; HUMANS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES;

EID: 0031965914     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(98)00025-6     Document Type: Conference Paper

References (23)

1. Arioka M., Tsukamoto M., Ishiguro K., Kato R., Sato K., Imahori K., Uchida T. Tau protein kinase II is involved in the regulation of the normal phosphorylation state of τ protein. J. Neurochem. 60:1993;461-468.
2. Arriagada P. A., Growdon J. H., Hedley-White E. T., Hyman B. T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurol. 42:1992;631-639.
3. Goedert M. Tau protein and the neurofibrillary pathology of Alzheimer's disease. TINS. 16:1993;460-465.
4. Hoshi M., Murayama M., Yasutake K., Hoshino T., Ishiguro K., Takashima A., Imahori K. Effect of amyloid β-peptide (1-42) on cholinergic neuron Suppression of acetyl choline synthesis precedes neurodegeneration . J. Biol. Chem. 272:1997;2038-2041.
5. Hoshi M. M., Takashima A., Noguchi A., Murayama M., Sato M., Kondo S., Saitoh Y., Ishiguro K., Hoshino T., Imahori K. Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3β in brain. Proc. Natl. Acad. Sci. USA. 93:1996;2719-2723.
6. Hoyer S., Oesterreich K., Wagner O. Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type? J. Neurol. 235:1988;143-148.
7. Ihara Y., Nukina N., Miura R., Ogawara M. Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease. J. Biochem. (Tokyo). 99:1986;1807-1810.
8. Ishiguro K., Ihara Y., Uchida T., Imahori K. A novel tubulin-dependent protein kinase forming a paired helical filament epitope on tau. J. Biochem. (Tokyo). 104:1988;319-321.
9. Ishiguro K., Omori A., Sato K., Tomizawa K., Imahori K., Uchida T. A serine/threonine proline kinase activity is included in the tau protein kinase fraction forming a paired helical filament epitope. Neurosci. Lett. 128:1991;195-198.
10. Ishiguro K., Omori A., Takamatsu M., Sato K., Arioka M., Uchida T., Imahori K. Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments. Neurosci. Lett. 148:1992;202-206.
11. Ishiguro K., Takamatsu M., Tomizawa K., Omori A., Takahashi M., Arioka M., Uchida T., Imahori K. Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments. J. Biol. Chem. 267:1992;10897-10901.
12. Kanai Y., Chen J., Hirokawa N. Microtubule bundling by tau protein in vivo Analysis of functional domains . EMBO J. 11:1992;3953-3961.
13. Kobayashi S., Ishiguro K., Omori A., Takamatsu M., Arioka M., Imahori K., Uchida T. A cdc2-related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubule. FEBS Lett. 335:1993;171-175.
14. Mori H., Kondo J., Ihara Y. Ubiquitin is a component of paired helical filament in Alzheimer's disease. Science. 235:1987;1641-1644.
15. Morishima-Kawashima M., Hasegawa M., Takio K., Suzuki M., Yoshida H., Titani K., Ihara Y. Proline-directed and non-proline-directed phosphorylation of PHF-τ J. Biol. Chem. 270:1995;823-829.
16. Shiurba R. A., Ishiguro K., Takahashi M., Sato K., Spooner E. T., Mercken M., Yoshida R., Wheelock T. R., Yanagawa H., Imahori K., Nixon R. A. Immunocytochemistry of tau phosphoserine413 and tau protein kinase I in Alzheimer pathology. Brain Res. 737:1996;119-132.
17. Sorbi S., Bird E. D., Blass J. P. Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann. Neurol. 13:1982;72-78.
18. Takashima A., Noguchi K., Sato K., Hoshino T., Imahori K. Tau protein kinase I is essential for amyloid β-protein-induced neurotoxicity. Proc. Natl. Acad. Sci. USA. 90:1993;7789-7793.
19. Tsukamoto M., Kato R., Ishiguro K., Uchida T., Sato K. Improved protective groups for phosphate of o-phosphoserine useful for the solid-phase peptide synthesis. Tetrahedron Lett. 32:1991;7083-7086.
20. Watanabe A., Hasegawa M., Suzuki M., Takio K., Morishima-Kawashima M., Titani K., Arai T., Kosik K. S., Ihara Y. In vivo phosphorylation sites in fetal and adult rat tau. J. Biol. Chem. 268:1993;25712-25717.
21. Webb, E. C. Enzyme Nomenclature. Recommendations 1984. Supplement 3: Corrections and additions. Eur. J. Biochem. 187:263-281; 1990.
22. Whitehouse P. J., Price D. L., Struble R. G., Clark A. W., Coyle J. T., DeLong M. R. Alzheimer's disease and senile dementia loss of neurons in the basal forebrain . Science. 215:1982;1237-1239.
23. Yamaguchi H., Ishiguro K., Uchida T., Takashima A., Lemere C. A., Imahori K. Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK)I/GSK-3β and cdk 5, a component of TPKII. Acta Neuropathol. 92:1996;232-241.